Last updated on August 2018

Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: NIDDM | Diabetes Mellitus
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Type 1 or type 2 diabetic patients
  • Performing auto-glycaemic control (at least 2 glycemias a day)
  • Treated with insulin by a basal-bolus regimen for at least 1 year and using the same method of administration for at least 3 months (insulin pen or pump)
  • Who have an Apple or Androde Smartphone compatible, or intend to acquire one before their participation in the study
  • Whose HbA1c dating of less 1 month and more than 3 months is 8%
  • Who are able to understand and follow the study protocol
  • Who have given their signed consent to take part in the study
  • Subject affiliated to the French National Health Insurance funds or benefiting from such insurance

Exclusion Criteria:

  • Age < 18 years old
  • Patients who have used the DIABEO system within 6 months before inclusion
  • Participation in a clinical study within 6 months, except for the Meos (or tldiab 3) study after a participation period of 6 months
  • Patients who are pregnant or who wish to become pregnant during the study.
  • Patients treated with human insulin A patient pre-screening register will be set up in each centre to establish the reasons for DM1/DM2 patients treated with a basal-bolus insulin regimen who are not taking part in the study.

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.